The Frankincense Extracts Market, estimated at USD 385.2 Mn in 2025, is expected to exhibit a CAGR of 8.44% and reach USD 679.2 Mn by 2032.
The Consumer Goods sector remains a vital driver of global growth, as organizations respond to evolving consumer expectations with sustainable practices, ethical production, and innovative product development. At the same time, advances in e-commerce, digital transformation, and supply chain optimization are reshaping the industry landscape, enhancing competitiveness, and unlocking new opportunities for long-term growth and collaboration.
Frankincense, also called as Olibanum, is referred as a gummy exudates, which is obtained from the trees of genus Boswellia and family Burseraceae. It grows especially in Somalia and Saudi Arabia. Frankincense extracts is known for its application in rheumatoid arthritis, ulcerative colitis, sore throats, asthma, and others, which in turn increases demand from the pharmaceutical industry. According to International Federation of Pharmaceutical Manufacturers & Association, the global pharmaceutical market is to reach around US$ 1,430 Billion by 2022. However, researchers from Ethiopia and the Netherlands found that the Boswellia tree, which produces frankincense are decreasing due to excessive grazing, fire, and beetle attack, and this can negatively impact the market growth.
The frankincense extract market is segmented based on form, end use, and region. Based on form the market is classified into powder, oil, and resin. Based on end use, it is categorized into food & beverage, cosmetics & personal care, aromatherapy, pharmacological, insecticide, and others.
COVID-19 is an incomparable global public health emergency that affected almost every industry, and long-term effects of covid-19 are projected to impact the industry growth during the forecast period.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/frankincense-extracts-market-1889